groupH
  • About Us
    • How We Work With You
    • Values
    • History
  • Team
  • Services
    • Decisions We Inform
    • Forecasting Event
  • Tools
    • Devil’s Advocate Tool
    • Gross-to-Net Tool (US)
    • Inflation Reduction Act (IRA) Tool
    • MAPPI Tool
    • Peak Share Tool
    • US Pricing Tool
  • Our Work
    • view by Therapy Area
    • view by Our Services
  • How We Work
  • Clients
  • Insights
  • News & Events
  • Careers
  • Contact Us
  • Menu Menu
groupH

About groupH

This author has not written his bio yet.
But we are proud to say that groupH contributed 37 entries already.

Entries by groupH

Understanding the impact of rare diseases on the quality of life of patients and their relatives

6th April 2022/in White Papers

The North American Neuro-Ophthalmology Society’s (NANOS) 48th Annual Meeting took place on February 12-17, 2022 in Austin, Texas In collaboration with Cambridge University and Gensight Biologics, groupH published a poster at the conference based on the findings of a qualitative study to explore the impact of Leber Hereditary Optic Neuropathy (LHON) on patients’ and their […]

2022 : groupH remains carbon neutral

15th January 2022/in News

Since its inception in 2005 the virtual working model of groupH has meant our impact on the planet, due to emissions, has always been minimal. Employees only travel for essential business and home-office working erases the need for a daily commute or a separate building infrastructure with its inherent energy needs. In 2022 we are […]

Understand US Payer contracting trends and use our Gross-to-Net Easy Tool to calculate future US net prices

15th October 2021/in White Papers

groupH has developed a simple US gross-to-net discount model including a proof-of-concept validation. This simple tool estimates applicable gross-to-net contracting discounts in the context of early-stage commercial assessments in the US market. The model has been developed based on in-depth primary market research with senior payers and secondary analysis. This paper was first presented during […]

Estimating Global Patient Needs and Market Potential for Priority Health Technologies Addressing Antimicrobial Resistance

1st September 2021/in White Papers

A groupH team has worked with the AMR Global R&D Hub over the last 12 months to produce data and analysis for a report on epidemiology and revenue projections for two therapeutics and two diagnostics in the Gram-negative space. Click on the image below to read the full report, delivering commercial insights into novel treatments […]

Microbiome Therapeutics – Commercialization Opportunities and Challenges

18th August 2021/in White Papers

Forecasting and Data Analytics Presentations – EphMRA 2021

11th June 2021/in New Horizons

At this year’s EphMRA annual conference (online, 15-17 June), Erik Holzinger will be involved in 4 sessions covering Forecasting and Data Analytics: Connecting the dots of your forecast through Decision influence modelling. Erik will convene a session discussing how to incorporate the views of multiple stakeholders when assessing the market potential of a new product. […]

Gene Therapy – Commercialization Opportunities and Challenges

4th June 2021/in White Papers

CAR-Ts – Commercialization Opportunities and Challenges

18th May 2021/in White Papers

EphMRA Forecasting Forum – A Discussion with Richard Murgatroyd from Roche

6th May 2021/in Events

A new series of Forecasting Forums are planned for 2021. This year we would like to extend the offer of the forum particularly to more junior, aspiring colleagues in forecasting and commercial decision making. We aim to shed light on: What makes people in different roles tick? What does a typical week in a certain […]

2021 : groupH becomes carbon neutral

12th January 2021/in News

Since its inception in 2005 the virtual working model of groupH has meant our impact on the planet, due to emissions, has always been minimal.  Employees only travel for essential business and home-office working erases the need for a daily commute or a separate building infrastructure with its inherent energy needs. We have now quantified […]

Page 1 of 41234

Pages

  • Devil’s Advocate Tool
  • Download Form
  • Download270319
  • Gross-to-Net (US) Tool
  • History
  • Home
  • Inflation Reduction Act Tool
  • Peak Share Tool
  • Tools
  • US Pricing Tool
  • About Us
  • Decisions We Inform
  • How We Work With You
  • Therapy Area
  • Service Offering
  • Team
  • Values
  • Forecasting Event
  • Services
  • MAPPI Tool
  • Our Work
  • Clients
  • How We Work
  • Our Insights
  • News & Events
  • Contact us
  • Register
  • Careers
  • Cookie Policy
  • Privacy Policy
  • Sitemap
  • Terms & Conditions
  • Training Terms & Conditions

Categories

  • Autoimmune
  • Briefing Note
  • Careers
  • CNS
  • Comment
  • Competitor workshops
  • Demand assessments
  • Dermatology
  • Disease area strategy
  • Events
  • Infectious Disesases
  • Inspiration
  • Interview
  • Market landscaping
  • New Horizons
  • News
  • Oncology
  • Scenario planning workshops
  • Team
  • TPP shaping and validation
  • Uncategorised
  • White Papers

Archive

  • May 2026
  • December 2025
  • August 2025
  • April 2025
  • February 2025
  • December 2024
  • October 2024
  • September 2024
  • June 2024
  • May 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • June 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • July 2022
  • April 2022
  • January 2022
  • October 2021
  • September 2021
  • August 2021
  • June 2021
  • May 2021
  • January 2021
  • December 2020
  • October 2020
  • June 2020
  • May 2020
  • December 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • March 2019
  • December 2018
  • September 2018
  • August 2018
  • May 2018
  • December 2017
  • October 2017
  • September 2017
  • June 2017
  • May 2017
  • December 2016
  • November 2016
  • October 2016
  • May 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • June 2015
  • April 2015
  • March 2015
  • December 2014
  • September 2014
  • November 2013
  • July 2013
  • June 2013
  • April 2013
  • March 2013
  • February 2013
  • December 2012
  • November 2012
  • September 2012
  • February 2012
  • December 2010

© groupH Ltd

LinkedIn
newsletter
Vimeo

  • Contact us
  • Tools
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Sitemap
Scroll to top Scroll to top Scroll to top
By continuing to use this website you will be agreeing to our Terms & Conditions, our Privacy Policy, and the use of cookies.